1Amending the act of September 9, 1965 (P.L.497, No.251),
2entitled, as amended, "An act requiring physicians, hospitals
3and other institutions to administer or cause to be
4administered tests for genetic diseases upon infants in
5certain cases," providing for congenital heart defects

7The General Assembly of the Commonwealth of Pennsylvania
8hereby finds and declares as follows:

9(1) Congenital heart defects (CHDs) are structural
10abnormalities of the heart that are present at birth. CHDs
11range in severity from simple problems such as holes between
12chambers of the heart, to severe malformations, such as
13complete absence of one or more chambers or valves. Some
14critical CHDs can cause severe and life-threatening symptoms
15which require intervention within the first days of life.

16(2) According to the United States Secretary of Health
17and Human Services' Advisory Committee on Heritable Disorders
18in Newborns and Children, congenital heart disease affects

1approximately seven to nine of every 1,000 live births in the
2United States and Europe. The Centers for Disease Control and
3Prevention states that CHD is the leading cause of infant
4death due to birth defect.

5(3) Current methods for detecting CHDs generally include
6prenatal ultrasound screening and repeated clinical
7examinations. While prenatal ultrasound screenings can detect
8some major congenital heart defects, these screenings, alone,
9identify less than half of all CHD cases, and critical CHD
10cases are often missed during routine clinical exams
11performed prior to a newborn's discharge from a birthing

13(4) Pulse oximetry is a noninvasive test that estimates
14the percentage of hemoglobin in blood that is saturated with
15oxygen. When performed on a newborn a minimum of 24 hours
16after birth, pulse oximetry screening is often more effective
17at detecting critical, life-threatening CHDs which otherwise
18go undetected by current screening methods. Newborns with
19abnormal pulse oximetry results require immediate
20confirmatory testing and intervention.

21(5) Many newborn lives could potentially be saved by
22earlier detection and treatment of CHDs if birthing
23facilities in this Commonwealth were required to perform this
24simple, noninvasive newborn screening in conjunction with
25current CH screening methods.

26This act shall be referred to as the James Matthew Mannix

28The General Assembly of the Commonwealth of Pennsylvania
29hereby enacts as follows:

30Section 1. Section 3 of the act of September 9, 1965

1(P.L.497, No.251), known as the Newborn Child Testing Act, is
2amended by adding a subsection to read:

3Section 3. Newborn Child Screening and Follow-up Program.--*
4* *

5(a.1) The department shall require each health care provider
6that provides birthing and newborn care services to perform a
7pulse oximetry screening a minimum of 24 hours after birth on
8each newborn child in its care.

9* * *

10Section 2. This act shall take effect in 90 days.